Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × farletuzumab × Clear all

NCT00738699 2017-03-30

FAR-122

Phase 2 Terminated

415 enrolled 11 charts

Ovarian Neoplasms

NCT00318370 2015-09-09

Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy

Phase 2 Completed

58 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms